Search
Search Results
##search.searchResults.foundPlural##
-
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3343PDF: 1495HTML: 14023jdoe, Dening.MarijuanaFi7.doc: 247jdoe, Dening.MarijuanaFi6.doc: 235jdoe, Dening.MarijuanaFi5.doc: 224jdoe, Dening.MarijuanaFi4.doc: 237jdoe, Dening.MarijuanaFi3.doc: 246jdoe, Dening.MarijuanaFi2.doc: 296jdoe, Dening.MarijuanaFig1.doc: 263 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1703PDF: 1042HTML: 240 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3360PDF: 1253HTML: 512 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5544PDF: 1423HTML: 2885Cover letter: 250 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1504PDF: 887HTML: 8682Fig 3 Savini: 232Fig 2 Savini: 238Fig 1 Savini Chest TC: 234Author letter to referees: 238 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3727PDF: 1293HTML: 531 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3485PDF: 1660HTML: 295 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1665PDF: 1098HTML: 150 -
-
Antimicrobial Stewardship in a world racked by conflict and uncertainty: A Call for global resilience AMS in conflict areas
460PDF: 213Html: 57 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
110PDF: 201Suppl. Files: 36Html: 118Html Suppl. Files: 95 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1441PDF: 810HTML: 424 -
Simultaneous dual pathology in lymph node
1747PDF: 768HTML: 7856Simultaneous dual pathology in lymph node: 221Simultaneous dual pathology in lymph node: 237Simultaneous dual pathology in lymph node: 191Simultaneous dual pathology in lymph node: 234Simultaneous dual pathology in lymph node: 227 -
-
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2429PDF: 1025HTML: 528Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 411Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 309Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 321 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1703PDF: 1194HTML: 277 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3941PDF: 1651HTML: 3926Letter to Editor: 241 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1974PDF: 861HTML: 3699 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3072PDF: 1181HTML: 137 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2566PDF: 1315HTML: 4889table: 275fig 1: 291fig 2: 254 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7513PDF: 4143HTML: 24993 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
3040PDF: 1042HTML: 2124Cover letter: 226 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1442PDF: 1035HTML: 518 -
The diagnostic pitfalls of mucormycosis
1059PDF: 776HTML: 306 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2740PDF: 1043HTML: 15149







